These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26444978)

  • 21. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications.
    Döring F; Walter J; Will J; Föcking M; Boll M; Amasheh S; Clauss W; Daniel H
    J Clin Invest; 1998 Jun; 101(12):2761-7. PubMed ID: 9637710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
    Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.
    Jappar D; Hu Y; Smith DE
    Drug Metab Dispos; 2011 Dec; 39(12):2250-7. PubMed ID: 21880829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of intestinal PepT1 on the kinetics and dynamics of N-formyl-methionyl-leucyl-phenylalanine, a bacterially-produced chemotactic peptide.
    Wu SP; Smith DE
    Mol Pharm; 2013 Feb; 10(2):677-84. PubMed ID: 23259992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.
    Irie M; Terada T; Sawada K; Saito H; Inui K
    J Pharmacol Exp Ther; 2001 Aug; 298(2):711-7. PubMed ID: 11454935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro.
    Nielsen CU; Frølund S; Abdulhadi S; Sari H; Langthaler L; Nøhr MK; Kall MA; Brodin B; Holm R
    Br J Pharmacol; 2013 Nov; 170(5):1041-52. PubMed ID: 23962042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function and expression of the proton-coupled amino acid transporter PAT1 along the rat gastrointestinal tract: implications for intestinal absorption of gaboxadol.
    Broberg Ml; Holm R; Tønsberg H; Frølund S; Ewon KB; Nielsen Al; Brodin B; Jensen A; Kall MA; Christensen KV; Nielsen CU
    Br J Pharmacol; 2012 Oct; 167(3):654-65. PubMed ID: 22577815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity.
    Hu Y; Shen H; Keep RF; Smith DE
    J Neurochem; 2007 Dec; 103(5):2058-65. PubMed ID: 17854384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice.
    Ma K; Hu Y; Smith DE
    Pharm Res; 2012 Feb; 29(2):535-45. PubMed ID: 21904935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the mechanisms of uptake of 5-aminolevulinic acid derivatives by PEPT1 and PEPT2 transporters as a tool to improve photodynamic therapy of tumours.
    Rodriguez L; Batlle A; Di Venosa G; MacRobert AJ; Battah S; Daniel H; Casas A
    Int J Biochem Cell Biol; 2006; 38(9):1530-9. PubMed ID: 16632403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1.
    Groneberg DA; Döring F; Eynott PR; Fischer A; Daniel H
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G697-704. PubMed ID: 11518682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide transporter 1 is responsible for intestinal uptake of the dipeptide glycylsarcosine: studies in everted jejunal rings from wild-type and Pept1 null mice.
    Ma K; Hu Y; Smith DE
    J Pharm Sci; 2011 Feb; 100(2):767-74. PubMed ID: 20862774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of zinc on the absorption of JBP485 via the gastrointestinal oligopeptide transporter (PEPT1) in rats.
    Miao Q; Liu Q; Wang C; Meng Q; Guo X; Peng J; Kaku T; Liu K
    Drug Metab Pharmacokinet; 2011; 26(5):494-502. PubMed ID: 21712612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Active drug delivery by heterologous expression of membrane transporters].
    Sai Y
    Yakugaku Zasshi; 2003 Jun; 123(6):413-22. PubMed ID: 12822485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Silico Prediction of the Absorption and Disposition of Cefadroxil in Humans using an Intestinal Permeability Method Scaled from Humanized
    Hu Y; Smith DE
    Drug Metab Dispos; 2019 Mar; 47(3):173-183. PubMed ID: 30593545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1.
    Nässl AM; Rubio-Aliaga I; Fenselau H; Marth MK; Kottra G; Daniel H
    Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G128-37. PubMed ID: 21350187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and mechanism of intestinal absorption of JBP485 in rats.
    Cang J; Zhang J; Wang C; Liu Q; Meng Q; Wang D; Sugiyama Y; Tsuji A; Kaku T; Liu K
    Drug Metab Pharmacokinet; 2010; 25(5):500-7. PubMed ID: 20877133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
    Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
    Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile acid-regulated peroxisome proliferator-activated receptor-α (PPARα) activity underlies circadian expression of intestinal peptide absorption transporter PepT1/Slc15a1.
    Okamura A; Koyanagi S; Dilxiat A; Kusunose N; Chen JJ; Matsunaga N; Shibata S; Ohdo S
    J Biol Chem; 2014 Sep; 289(36):25296-305. PubMed ID: 25016014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance.
    Zhang Y; Sun J; Sun Y; Wang Y; He Z
    Curr Drug Metab; 2013 Jul; 14(6):675-87. PubMed ID: 23869811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.